Refine by
Preclinical Modeling Articles & Analysis
52 articles found
A 2026 study of human and animal models identifies concurrent inhibition of the transcription regulators ID1 and ID3 as a potential therapeutic approach, given their upregulation in fibroblasts from diseased tissue.Dual targeting of ID1 and ID3Single-agent inhibition is insufficient because ID1 and ID3 compensate for each other; simultaneous inhibition is required to yield ...
Idiopathic pulmonary fibrosis (IPF) is a devasting lung disease characterized by progressive scarring of lung tissue. As fibrosis develops, patients experience worsening shortness of breath, reduced lung capacity and ultimately respiratory failure. Current therapies for IPF rely on oral administration of pirfenidone and nintedanib, two FDA-approved drugs that slow disease progression. While ...
For instance, CXCL10 has shown promise in preclinical models by enhancing T-cell infiltration into tumors. Additionally, chemokines play a role in vaccine development. By co-administering chemokines like CCL19 or CCL21, researchers have improved antigen presentation and immune memory in several vaccine models. Emerging Research and Challenges ...
For example, research from the MD Anderson Cancer Center has shown that dual inhibition of both BCL2 and MCL1 can be effective in preclinical models of multiple myeloma. By targeting both of these anti-apoptotic proteins, the combination therapy can overcome resistance mechanisms that limit the effectiveness of single-agent therapies. ...
Minimal Sample Volume: Typically requiring only 25-50 µL of sample, this technology is invaluable for studies with limited sample availability, such as pediatric research, rare diseases, or precious preclinical models. Cost-Effectiveness: While an individual panel may seem more expensive than a single ELISA kit, the cost per analyte result is significantly ...
Pre-Clinical Analysis Services for RDCs Preclinical research is a crucial phase in the drug development process, particularly for Radiopharmaceuticals and Drug Conjugates(RDCs). ...
Offerings include comprehensive support in drug development, preclinical research, animal models, and strategic planning.Learn more about: cancer vaccine adjuvant development service ...
Preclinical drug discovery represents a critical phase in the development of new therapeutics. ...
Understanding the Importance of Animal Models Animal models serve as biological proxies for human disease, allowing scientists to study complex biological interactions and disease pathways. ...
Moreover, the services on ovarian cancer model development allow researchers to utilize state-of-the-art preclinical models that closely mimic human ovarian cancer biology. These models enable the in-depth study of tumor behavior and therapeutic response, facilitating the discovery of novel treatment avenues tailored to ...
Various preclinical models have been developed to mimic the multifaceted nature of NAFLD. ...
These respiratory issues, such as apneas and irregular breathing patterns, are not only hallmark symptoms of RTT but also serve as critical indicators of disease progression and therapeutic efficacy in preclinical studies. With advancements in non-invasive respiratory monitoring and telemetry integration, researchers are gaining unprecedented insights into the impact of ...
Furthermore, while liposomes have shown promise in preclinical models, translation to the clinical setting has been met with variable success. Factors such as complex in vivo dynamics and interpatient variability can affect liposome pharmacokinetics and biodistribution, underscoring the need for more predictive preclinical models ...
Alfa Cytology’s team of scientists can design more effective vaccine programs, and conduct preclinical evaluations on the safety and efficiency of vaccines. Moreover, to further explore the mechanism of PC occurrence, development, invasion, and metastasis, Alfa Cytology independently developed PC model construction services, dedicated to offering different ...
This blog delves into a fascinating study that investigates how altered ventilatory responses to hypercapnia-hypoxia (HH) challenges in a preclinical SUDEP model implicate orexin ...
Usually, the drug development process of small molecule drugs includes identification and validation of initial targets, screening of lead compounds, method development and modeling, pharmacokinetic characterization, preclinical safety assessment, selection of preclinical drug candidates, and clinical studies. ...
Advances in molecular design, chemical modification, and delivery have enabled the systemic in vivo application of PNAs to enable gene editing in preclinical mouse models. In a β-thalassemia model, treated animals exhibited clinically relevant protein recovery and disease phenotype improvements, suggesting the potential for therapeutic ...
Quality Control of Aluminum-adjuvanted Vaccines First, the nature of the surface charge of aluminum-adsorbed antigens needs to be understood in order to predict the physical properties of vaccine suspensions; Second, determining the rate and strength of adsorption of aluminum adsorbed antigens can help us to understand the ability of aluminum adjuvants to adsorb antigens, as well as their ...
Due to their low prevalence and limited understanding, treating and finding cures for these conditions present significant challenges. However, preclinical animal models have emerged as invaluable resources for advancing research and unraveling the mysteries surrounding rare diseases. ...
It is worth noting that the REGN5093-M114 naked antibody itself also has a certain effect in inhibiting tumors and has demonstrated good efficacy in various preclinical models. M1231 The targets of most bispecific ADCs are two different epitopes of the same target, such as the three products above. ...